Skip to main content
Clinical Trials/NCT05674435
NCT05674435
Completed
Not Applicable

Clinical Utility of Neuromodulation on Tinnitus: A Systematic Review

Hearing and Language Healthcare Center, China Medical University Hsinchu Hospital, Taiwan1 site in 1 country26 target enrollmentJanuary 1, 2022
ConditionsTinnitus

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Tinnitus
Sponsor
Hearing and Language Healthcare Center, China Medical University Hsinchu Hospital, Taiwan
Enrollment
26
Locations
1
Primary Endpoint
Tinnitus severity scores
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The aim of the present narrative review is to one of the first to critically evaluate the clinical effectiveness of neuromodulation as a therapeutic option for patients with tinnitus. Our method involves conducting a systemic review and the findings reported following PRISMA statement. Pubmed, Cochrane database and Google Scholar databases literature search was conducted for articles reporting the use of neuromodulatory interventions on tinnitus patients. Each article was evaluated using the Cochrane risk of bias tool.

Registry
clinicaltrials.gov
Start Date
January 1, 2022
End Date
September 30, 2022
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Hearing and Language Healthcare Center, China Medical University Hsinchu Hospital, Taiwan
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Tinnitus patients
  • At least one of the neurofeedback methods
  • Single and multi-center
  • Randomized control trials and observational studies

Exclusion Criteria

  • Non-peer-reviewed papers, letters, editorials
  • Not English language

Outcomes

Primary Outcomes

Tinnitus severity scores

Time Frame: 9 months

Study Sites (1)

Loading locations...

Similar Trials